Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Chiesi: key pharmaceutical brands produced 2016-2017, by revenues

Worldwide key brand drugs produced by the Italian pharmaceutical company Chiesi in 2016 and 2017, by revenues (in million euros)

Chiesi: key pharmaceutical brands produced 2016-2017, by revenues This statistic depicts the revenues of the main brand drugs produced and distributed by the Italian pharmaceutical company Chiesi in 2016 and 2017. According to the figure, the earnings generated through the sales of the key products increased for each of them over the two years. In 2017, the revenue related to the commercialization of Foster amounted to 665 million euros.
Show more

Worldwide key brand drugs produced by the Italian pharmaceutical company Chiesi in 2016 and 2017, by revenues (in million euros)

20162017
---
---
---
20162017
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic depicts the revenues of the main brand drugs produced and distributed by the Italian pharmaceutical company Chiesi in 2016 and 2017. According to the figure, the earnings generated through the sales of the key products increased for each of them over the two years. In 2017, the revenue related to the commercialization of Foster amounted to 665 million euros.
Show more
Release date
2017
Region
Italy
Survey time period
2016 and 2017
Supplementary notes
The source adds the following information: “The brand drugs mentioned refers to the respiratory therapeutic class, the one in which Chiesi is a key player at global level”.
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical industry in Italy
Pharmaceutical industry in Italy

All Information
in one Presentation

Pharmaceutical industry in Italy

Everything On "Pharmaceutical industry in Italy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical industry in Italy"
  • Industry overview
  • Key players
  • International trade
  • Research and development
  • CDMO
  • Forecasts
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.